Feedback Share Discussion Threads

[dplewis1] 18/11/2019 12:11

Has the AGM finished now? Was anyone there?

[yump] 18/11/2019 11:45

Seems to me that if they've got IP on Bleepa and its system agnostic, then there may be opportunities to licence in some way, as licencees of various types will have way more access to customers than FDBK ploughing along with their own sales process.

[ged5] 18/11/2019 11:13

OK CZ, best of luck to you.

[ged5] 18/11/2019 10:59

Thanks Phurley.

For example, the transfer of images does not give the radiologist receiving the images the opportunity to follow up with other patient procedures. Therefore, they must convey the appropriate information to the on-site doctors. This is not always effective and can often lead to miscommunication and confusion.

Furthermore, teleradiology is entirely dependent on technology so should there be no access to the internet (e.g. if the hospital’s internet is down for service), teleradiology is no longer an option and patients will remain undiagnosed or even untreated.



Seems like they need Bleepa!

[ged5] 18/11/2019 10:54

The Pennine Acute Hospitals NHS Trust (Pennine) is one of the biggest in the North West region, and has some of the largest services by volume in the whole of England. Pennine operates from four main sites in North Manchester, Bury, Oldham and Rochdale, together with the Floyd Unit at Birch Hill Hospital. Our team of over 9,000 staff provides a wide range of acute, specialist and community services to over 800,000 people across the North East of Greater Manchester, in Bury, North Manchester, Middleton, Heywood, Oldham and Rochdale, and parts of East Lancashire.

From the 1 April 2017, the Northern Care Alliance NHS Group (NCA) was launched, bringing together over 17,000 staff, 2000 beds and serving a population of over 1 million.

[czc9] 18/11/2019 10:47

Yes I have now sold. It seems fdbk still has blind faith from a lot of backers which I understand because I was there but they've had too many chances to achieve something meaningful. I had said previously I would buy again at 0.8 but not now. I wish you all good luck.

[phurley] 18/11/2019 10:39

Just hang fire. They are in talks with the leading teleradiology companies. Could be substantial rerating if there is a deal.

[ged5] 18/11/2019 09:54

I've certainly not brushed your post off. I've counter argued your statement which wasn't backed up with evidence with a quote from the RNS. I do agree about the need for income. It will be a tight call whether there will be a need to raise cash in the 2nd quarter next year. I think I've posted before that income will be needed above and beyond what TexRAD is bringing in.

You've been concerned about FDBK in a few of your posts so I presume you are selling or sold.

FDA approval hasn't been binned it has been paused. I thought there were some positive comments about TexRAD and I was pleased there was an explanation about the delay for approval.

Also the statement from Tom Oakley included this very positive comment:-

"We have received interest from clinicians and professionals across both public and private hospitals, within the UK and internationally....the outcome of this pilot is expected to provide the evidence base to support a number of commercial opportunities for BleepaⓇ.

[yump] 18/11/2019 09:46

texrad has not been abandoned - that is just incorrect - its the effort put into FDA approval that has been reduced. I think the priority is right to conserve cash in order to support Bleepa. What happens with that remains to be seen of course. It might come to nothing, as with any new products.

The worst case imo is that they follow the sunk cost fallacy and put lots of effort into texrad, just because it has already consumed a load.

[yump] 18/11/2019 09:42

The pilot news is obviously independent of the share price and I don't think it would be wise to judge the news by the lack of share price reaction. Pilots were expected anyway and its one. imo will have to wait for some results from pilots, or a collection of pilots for any significant enthusiasm to appear. Pilots in the NHS usually take quite a while to even get going, so I'm looking for a fairly quick collection of pilots.

That would mean firstly that its not taking a load of cross-department agreement before a decision is made and secondly that there are few clinical barriers to pilots. That would be very different from the usual clinical trials of med devices which seem to take an age.

Admittedly I'm a recent investor but strategically I would have hated to see money thrown at texrad for some vague possibility of overseas sales, when UK sales are actually pretty minimal.

[regina61] 18/11/2019 09:40

Shocking RNS. With TexRad effectively abandoned FDBK becomes a start-up with an unproven product, no sales even likely for many months. But this start up comes with a market cap of £5m and mega payroll. A trial is just that, a trial - it could be trialled by any number of hospitals (I wonder how much it costs FDBK to run a trial?) and result in zero take up.

[czc9] 18/11/2019 09:30

Based on my fdbk experience yes that's what I expect Ged. Just my opinion but it's heading in a concerning direction. My post on a BB has no impact on the share price but to brush it off is unwise. I was hoping for a real bounce on pilot news but that's not what has happened. FDBK needs income and soon. The prospect of jam tomorrow has happened too often with fdbk and the dilution is severe.

[ged5] 18/11/2019 09:05

No news due for a while? Are you sure?

"The Pennine Acute Hospitals NHS Trust pilot study is our first, but with the interest we have received since the launch of Bleepa at the NHS Expo 2019 in September, we anticipate more to follow."

[czc9] 18/11/2019 08:57

Very worrying RNS in my opinion. One pilot study with nothing concrete attached. share price down and no news due for a while. FDA approval binned. GLA you need it.

[ged5] 18/11/2019 08:41

Surprised to see this marked down first thing. At last they've opened up about FDA approval. Bleepa is about to be trialled and hopefully other trials will follow.

The journey begins!

[yump] 18/11/2019 08:18

Wrt any med device the phrase ‘further clinical data’ is a bit of a stumbling block. Makes sense to not put a load of resources into texrad / fda approval. Trying to sell overseas when uk sales aren’t thriving never seems to work out and even with fda approval, there would still be a load of costs involved. Imo keep the core business ticking over at minimum expense and concentrate on bleepa. A much simpler sell with relatively simple assessment needed by potential users.

[dplewis1] 18/11/2019 08:08

Got offered way over..nothing done.

[dave4545] 18/11/2019 08:02

Cannot buy a bean online.

Unless people sell that mark down is only designed for people that panic sell not to let others buy any size.

[dplewis1] 18/11/2019 07:42

There's plenty of cash left. They got the app built by a company in Poland, but you're clearly a bit of a moron so enough with you.

[nobilis] 18/11/2019 07:21

How much cash is left?
U can get a bleeps app built for 5k in Romania

Placing at half a penny lol

[dplewis1] 18/11/2019 07:09

On a company note, it's bleepa or bust then..

[dplewis1] 18/11/2019 07:09

Ah Casper786. Are you using this one because you got into trouble for offensive posting with your newtothisgame3 account?